Stem Cell Therapy for Pets: Gallant's FDA Push Explained

Stem Cell Therapy for Pets: Gallant's FDA Push Explained

Stem Cell Therapy for Pets Is Getting Closer to Reality Ready-made stem cell therapy for pets is no longer just a futuristic concept—it’s on the brink of becoming a real treatment option, thanks to a biotech startup called Gallant. The San Diego-based company recently secured $18 million in funding to fast-track the first FDA-approved off-the-shelf stem cell treatment for animals. This marks a major step forward in veterinary medicine, offering a potential breakthrough in how we care for cats and dogs suffering from chronic conditions. Gallant’s approach stands out because it eliminates the need to harvest cells from each individual pet—something that currently makes stem cell therapy costly, time-consuming, and out of reach for most pet owners. Image Credits:Olga Zarzycka / 500px / Getty Images How Ready-Made Stem Cell Therapy for Pets Works Traditional stem cell therapies for pets typically involve extracting tissue from the animal being treated, processing it in a lab, and then re-inje…